Relative mortality and epoetin alpha dose in hemodialysis patients.
作者信息
Cotter Dennis J, Thamer Mae, Zhang Yi
出版信息
Am J Kidney Dis. 2008 May;51(5):865; author reply 865-6. doi: 10.1053/j.ajkd.2007.12.045.
PMID:18436099
Abstract
摘要
相似文献
1
Relative mortality and epoetin alpha dose in hemodialysis patients.
Am J Kidney Dis. 2008 May;51(5):865; author reply 865-6. doi: 10.1053/j.ajkd.2007.12.045.
2
Relative mortality and epoetin alpha dose among hemodialysis patients.
Am J Kidney Dis. 2008 May;51(5):866-7; author reply 867. doi: 10.1053/j.ajkd.2008.01.028.
3
4
Switching epoetin alfa and epoetin zeta in patients with renal anemia on dialysis: Posthoc analysis.
Adv Ther. 2010 Dec;27(12):941-52. doi: 10.1007/s12325-010-0080-z. Epub 2010 Oct 22.
5
Comparison of the therapeutic effects of epoetin zeta to epoetin alfa in the maintenance phase of renal anaemia treatment.
Curr Med Res Opin. 2008 Mar;24(3):625-37. doi: 10.1185/030079908X273264.
6
Epoetin bubble: a severe German case Honi soit qui mal y pense.
Nephrol Dial Transplant. 2011 May;26(5):1750-2; author reply 1752. doi: 10.1093/ndt/gfr016. Epub 2011 Mar 4.
7
Assessing the impact of concomitant therapies on anemia in dialysis patients. Case study of the anemic patient.
Nephrol Nurs J. 2000 Jun;27(3):320-3; quiz 324-5.
8
Revisions in the prescribing information for Epoetin alfa: implications for nephrology nurses and patients on dialysis.
Nephrol Nurs J. 2008 Mar-Apr;35(2):163-7.
9
Chronic kidney disease, anemia, and epoetin.
N Engl J Med. 2007 Mar 1;356(9):957-8; author reply 958-9.
10
Anemia: dialysis patients experiences.
Nephrol News Issues. 2004 Nov;18(12):49-54.
引用本文的文献
1
Individualizing anaemia therapy.
NDT Plus. 2010 Dec;3(6):519-26. doi: 10.1093/ndtplus/sfq164. Epub 2010 Sep 21.
2
Pretransplantation erythropoiesis-stimulating agent hyporesponsiveness is associated with increased kidney allograft failure and mortality.
Transplantation. 2013 Nov 15;96(9):807-13. doi: 10.1097/TP.0b013e3182a0f668.
Zotero 插件